Zobrazeno 1 - 10
of 335
pro vyhledávání: '"Dilute Russell's viper venom time"'
Publikováno v:
Exploration of Immunology, Vol 3, Iss 5, Pp 416-432 (2023)
Antiphospholipid syndrome (APS) is defined as an autoimmune and prothrombotic disorder in patients with the persistent presence of antiphospholipid antibodies (aPLs). In the classification criteria, aPL expresses lupus anticoagulant (LA) activity, wh
Externí odkaz:
https://doaj.org/article/467ad1c463c94856aeed6cf989a3dd68
Autor:
Gary W. Moore
Publikováno v:
Exploration of Immunology, Vol 3, Iss 4, Pp 300-324 (2023)
Accurate lupus anticoagulant (LA) detection is crucial to antiphospholipid syndrome (APS) diagnosis. Detection is based on LA functional behavior in coagulation assays irrespective of epitope specificity. LA screening tests employ dilute phospholipid
Externí odkaz:
https://doaj.org/article/822bb8fc6a7846fba4268c1eb122d153
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
American Journal of Clinical Pathology. 156:1073-1082
Objectives Lupus anticoagulant (LA) detection requires (1) prolongation of a phospholipid (PL)–dependent clot-based screening assay, (2) noncorrection upon adding normal pooled plasma, and (3) a confirmatory PL dependency test. Paired LA assays run
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0e3fec4d2ad59cbec35f484d8864bf4
https://doi.org/10.1093/ajcp/aqab069
https://doi.org/10.1093/ajcp/aqab069
Autor:
Pramod Kumar Pamu
Publikováno v:
International Journal of Clinical and Diagnostic Pathology. 3:12-15
Background: Anti-phospholipid antibody syndrome is a life-threatening acquired disorder of the immune system which can lead to dysfunction of the multiple systems in the human body. Lupus anticoagulant (LA) detection by the normalized dilute Russell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8fc7effd28caf45b4a2f56679462a1c6
https://doi.org/10.33545/pathol.2020.v3.i4a.305
https://doi.org/10.33545/pathol.2020.v3.i4a.305
Publikováno v:
Journal of Thrombosis and Haemostasis. 18:1124-1132
Background The concurrent presence of lupus anticoagulant, anticardiolipin, and anti β2-glycoprotein I antibodies (triple positive profile) identifies patients at high risk of thromboembolic events. These patients are also positive for anti-phosphat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3568778667fe7984323ac1570809593d
https://doi.org/10.1111/jth.14765
https://doi.org/10.1111/jth.14765
The term “lupus anticoagulant (LA)” identifies a form of antiphospholipid antibodies (aPLs) causing prolongation of clotting tests in a phospholipid concentration-dependent manner. LA is one of the laboratory criteria identified in patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55d3d0d89b78c798208ebdb8545b3683
http://hdl.handle.net/11562/1044951
http://hdl.handle.net/11562/1044951
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis
Clinical and Applied Thrombosis/Hemostasis, Vol 27 (2021)
Clinical and Applied Thrombosis/Hemostasis, Vol 27 (2021)
On an international scale, guidelines and proposals for lupus anticoagulant detection have been published over the last 20 years, but until now, standardization has not been completely realized. The aim of this study was to evaluate the different way
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::956b47255184d4841655119713381853
https://pubmed.ncbi.nlm.nih.gov/34657448
https://pubmed.ncbi.nlm.nih.gov/34657448